LSX Presentation Feb 2019 overview
London, UK, 05 February 2019. Dr. Michael Scherz, Founder & CEO of Metys Pharmaceuticals AG, has given a presentation at the LSX World Congress in London, on the story of MP-101 and the Company's plans for a Phase 2 clinical trial for prevention of chemotherapy-induced sensory symptoms of peripheral neuropathy. A link to a recording of the presentation is provided here: